Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial.

导出 OA

翻译打印收藏纠错

作者： Francesco,Perri ^[1] ; Francesco,Longo ^[2] ; Roberta,Fusco ^[3] ; Valeria,D'Alessio ^[3] ; Corrado,Aversa ^[4] ; Ettore,Pavone ^[4] ; Monica,Pontone ^[1] ; Maria Luisa,Marciano ^[1] ; Salvatore,Villano ^[4] ; Pierluigi,Franco ^[4] ; Giulia,Togo ^[5] ; Gianluca Renato De,Fazio ^[5] ; Daniele,Ordano ^[5] ; Fabio,Maglitto ^[4] ; Giovanni,Salzano ^[4] ; Maria Grazia,Maglione ^[4] ; Agostino,Guida ^[6] ; Franco,Ionna ^[4]

作者单位： Medical and Experimental Head and Neck Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Via M. Semmola, 80131 Naples, Italy. ^[1] Head and Neck Surgery Unit, Ospedale Casa Sollievo della Sofferenza, S. Giovanni Rotondo, 71013 Foggia, Italy. ^[2] IGEA SpA Medical Division-Oncology, Via Casarea 65, Casalnuovo di Napoli, 80013 Napoli, Italy. ^[3] Head and Neck Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Naples, Via M. Semmola, 80131 Naples, Italy. ^[4] School of Specialization in Maxillo-Facial Surgery, University of Naples Federico II, Via Sergio Pansini, 80131 Naples, Italy. ^[5] U.O.C. Odontostomatologia, AORN A. Cardarelli, 80131 Naples, Italy. ^[6]

关键词 electrochemotherapy randomized trial recurrent cell squamous carcinoma

DOI 10.3390/cancers13092210

PMID 34064511

发布时间 2021-06-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交